Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Myriad Genetics, Inc. MYGN recently published results from a meta-analysis in the Journal of Clinical Psychopharmacology, stating the superiority of the company’s GeneSight Psychotropic test over ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...
Courtney Nugent struggled with anxiety so debilitating it led to multiple hospitalizations. It wasn’t until her provider personalized her mental health medication treatment with the help of the ...
Dylan Eyestone submits a cheek swab as part of the GeneSight test he took through his mental healthcare provider, Dawn Johnson. The sample is analyzed in a lab and Johnson receives a report detailing ...
SALT LAKE CITY, July 01, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced the launch of a new patient home ...
SALT LAKE CITY, April 19, 2023 (GLOBE NEWSWIRE) -- From restricted or binge eating to excessive gambling to extreme social media use, 77% of Americans surveyed say they have used at least one ...
(NAPSI)—The latest GeneSight® Mental Health Monitor survey shows that nearly half of Americans feel they have lost time in their lives due to poor mental health. Courtney Nugent suffered a decade-long ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results